In view of these associations, Castan-Laurell et al. [15] suggest that apelin may act as an insulin sensitizing agent and may be a potential target for diabetes treatment, that is, given its potent activity in energy metabolism and ability to improve insulin sensitivity. Here, APLN is linked to diabetes mellitus.